Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05776719 · ClinicalTrials.gov registry record · NA
Efficacy of Virtual Warrior Renew Therapy for Veterans Who Experienced Military Sexual Trauma
A NA study of Post Traumatic Stress Disorder and Military Sexual Trauma (MST), sponsored by Seattle Institute for Biomedical and Clinical Research.
- Active
- Registry status
- NA
- Development phase
- 191
- Enrollment target
- 2
- Study locations
NCT05776719: Active NA study of Post Traumatic Stress Disorder and Military Sexual Trauma (MST), sponsored by Seattle Institute for Biomedical and Clinical Research.
NCT05776719 is a NA study of Post Traumatic Stress Disorder and Military Sexual Trauma (MST) that is active but no longer recruiting, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 191 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05776719, a NA study of Post Traumatic Stress Disorder and Military Sexual Trauma (MST), is active but no longer recruiting, sponsored by Seattle Institute for Biomedical and Clinical Research.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 191 participants
- Enrollment target
- 2
- Study locations
Study Summary
Group treatments may be helpful for Veterans who have experienced military sexual trauma (MST). By doing this study, the investigators hope to learn if two different groups: Warrior Renew and Health \& Wellness are effective in reducing mental health symptoms in Veterans who have experienced MST and if either is more effective than the other. Participation in this research will last about 16 weeks.
Primary Outcome
The 20-item PCL-550 will be used to assess symptoms of PTSD using items consistent with the Diagnostic and Statistical Manual 5 (DSM-5, 2013) criteria for PTSD. The wording of PCL-5 items reflects both changes to existing symptoms and the addition of new symptoms in DSM-5. The PCL-5 uses a self-report Likert rating scale of 0-4 for each symptom, including the anchors of: "Not at all," "A little bit," "Moderately," "Quite a bit," and "Extremely." A score of 31-33 has been identified as the optima
Conditions Studied
Interventions
- BEHAVIORAL Health & Wellness
- BEHAVIORAL Warrior Renew
Study Locations (2)
Oregon
- VA Portland Health Care System - Portland
Washington
- VA Puget Sound Health Care System - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2026-10-30 |
| Phase | NA |
What the registry record for NCT05776719 still lists
NCT05776719 is an interventional study that assigns participants to a tested intervention. The registered 191 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (71% lower).
The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Health & Wellness is the first listed.
NCT05776719 reports a single indexed study location in Oregon, Washington.
Frequently Asked Questions
What is clinical trial NCT05776719 about?
NCT05776719 is a clinical study titled "Efficacy of Virtual Warrior Renew Therapy for Veterans Who Experienced Military Sexual Trauma". Group treatments may be helpful for Veterans who have experienced military sexual trauma (MST). By doing this study, the investigators hope to learn if two different groups: Warrior Renew and Health \& Wellness are effective in reducing mental health symptoms in Veterans who have experienced MST and...
What is the current status of trial NCT05776719?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 191 participants. The study started on 2023-07-17. Estimated completion is 2026-10-30.
What conditions does trial NCT05776719 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Military Sexual Trauma (MST).
What interventions are being tested in trial NCT05776719?
The interventions under investigation include: Health & Wellness (BEHAVIORAL), Warrior Renew (BEHAVIORAL).
Who is sponsoring clinical trial NCT05776719?
This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05776719 being conducted?
This trial has 2 study locations across Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05776719's enrollment target sits among peer trials
191 60th of 262 higher than 203 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04621435 · 191 participants · Phase 1
Imaging of Solid Tumors Using FAP-2286
- NCT06810544 · 191 participants · Phase 1
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI